NCT06975436

Performance Study of the Cobas® BV/CV Test on Samples From Participants With and Without Symptoms of Bacterial Vaginosis and Candida Vaginitis

CompletedOBSERVATIONAL

Trial Details

Start: 2024-12-30Est. Completion: 2025-06-30

Enrollment target: 738 participants

Locations

Matrix Clinical Research, Los Angeles, California, United States
M3 Wake Research - San Diego at Convoy, San Diego, California, United States
Red Rocks OBGYN, Lakewood, Colorado, United States
Altus Research, Lake Worth, Florida, United States
Washington University, St Louis, Missouri, United States
Eastern Carolina Women's Center, New Bern, North Carolina, United States
Unified Women's Clinical Research/Lyndhurst, Winston-Salem, North Carolina, United States
Planned Parenthood Gulf Coast, Houston, Texas, United States
Diagnostic Consultative Center "Ascendent" Ltd., Sofia, Bulgaria
Centre Hospitalier Universitaire Vaudois (Chuv), Lausanne, Switzerland

Recurrent Bacterial Vaginosis

This randomized clinical trial aims to compare the recurrence of bacterial vaginosis (BV) in women receiving probiotics …

Multan, PakistanCompleted Jan 31, 2026

Vulvovaginal CandidiasesVulvovaginal Candidiasis, GenitalVulvovaginal Candidiasis (VVC)

This is a Phase 3 clinical study to evaluate the efficacy, safety, and tolerability of boric acid 600 mg vaginal inserts…

Mobile, United StatesCompleted Aug 12, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.